BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 36372245)

  • 1. Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
    Heather LC; Gopal K; Srnic N; Ussher JR
    Diabetes; 2024 May; 73(5):659-670. PubMed ID: 38387045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.
    Seferović PM; Paulus WJ; Rosano G; Polovina M; Petrie MC; Jhund PS; Tschöpe C; Sattar N; Piepoli M; Papp Z; Standl E; Mamas MA; Valensi P; Linhart A; Lalić N; Ceriello A; Döhner W; Ristić A; Milinković I; Seferović J; Cosentino F; Metra M; Coats AJS
    Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38896048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quest for Understanding Diabetic Cardiomyopathy: Can We Preserve Function and Prevent Failure?
    Lala A; Mentz RJ; Santos-Gallego CG
    J Am Coll Cardiol; 2024 Jul; 84(2):149-151. PubMed ID: 38888535
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic Cardiomyopathy-From Basics through Diagnosis to Treatment.
    Radzioch E; Dąbek B; Balcerczyk-Lis M; Frąk W; Fularski P; Młynarska E; Rysz J; Franczyk B
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference.
    Gupta K; Rawlley B; Meloche C; Minhas AMK; Hermel M; Slipczuk L; Sheikh S; Khoja A; Vaughan EM; Dalakoti M; Virani SS
    Curr Atheroscler Rep; 2024 Jun; ():. PubMed ID: 38829515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress.
    Ao L; Chen Z; Yin J; Leng Y; Luo Y; Fu X; Liu H; Liu X; Gao H; Xie C
    Front Pharmacol; 2023; 14():1290023. PubMed ID: 38027018
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice.
    Hsuan CF; Teng SIF; Hsu CN; Liao D; Chang AJ; Lee HL; Hee SW; Chang YC; Chuang LM
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
    Januzzi JL; Del Prato S; Rosenstock J; Butler J; Ezekowitz J; Ibrahim NE; Lam CSP; Marwick T; Wilson Tang WH; Liu Y; Mohebi R; Urbinati A; Zannad F; Perfetti R
    Cardiovasc Diabetol; 2024 Feb; 23(1):49. PubMed ID: 38302936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
    Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Perfetti R; Rosenstock J; Solomon SD; Tang WHW; Zannad F
    J Am Coll Cardiol; 2024 Jul; 84(2):137-148. PubMed ID: 38597864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center.
    Swiatkiewicz I; Patel NT; Villarreal-Gonzalez M; Taub PR
    BMC Med; 2024 May; 22(1):195. PubMed ID: 38745169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
    Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
    Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
    Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Rosenstock J; Tang WHW; Zannad F; Lawson F; Perfetti R; Urbinati A
    Am Heart J; 2023 Feb; 256():25-36. PubMed ID: 36372245
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.